MARATTO

article · Mansoura Nursing Journal

Enhancement of Oncology Nurses' Competency Regarding Management of Intravenous Chemotherapy Extravasation

2024Open accessMansoura University

Abstract

Background: Chemotherapy extravasation is serious problem, causing a damage that may range from a minorskin reaction to full-thickness burn , muscle , tendon necrosis and results in extending hospital stays, increasingmorbidity, and treatment costs. Aim: Enhance oncology nurses' competency regarding management of intravenouschemotherapy extravasation. Method: A quasi-experimental design one-group pretest posttest was used with a sample of63 nurses working at the medical department and chemotherapy installation unit at Oncology Center at MansouraUniversity Hospital. Tools: Two tools were used: Tool 1: Structured Interview questionnaire . Tool 2: Nurses’ practiceobservational checklist. Results: Nurses’ knowledge levels improved regarding chemotherapy extravasation posteducational intervention (80.7%) compared to (7%) pre educational intervention(P value <0.001*). Nurses’ practicelevels improved post educational intervention(86%) compared to (50.9%) pre educational intervention(P value<0.001*). Conclusion: There was statistically significant improvement in nurses’ competency regarding chemotherapyextravasation post educational intervention. Recommendation: Continuous in-service training programs for oncologynurses regarding prevention and management of intravenous chemotherapy extravasation to improve their knowledgeand practice.

Research topics

  • Chemotherapy-related skin toxicity
  • Cancer therapeutics and mechanisms
  • Neutropenia and Cancer Infections

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/mnj.2024.350496

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.